AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25186739 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater amounts of instrumental music training beyond 1 year
Number of subjects: 0
Study 21958377 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Tai Chi
Number of subjects: 152
Study 21958377 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 152
Study 21254641 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard antibacterial treatment plus immunotropic drug (lavomax) 1.25 g
Number of subjects: 40
Study 21254641 — intervention group
Group type: COMPARATOR
Intervention: Standard antibacterial treatment
Number of subjects: 40
Study 18294367 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise programme (1-hour sessions, 3 times per week for 8 months)
Number of subjects: 33
Study 18294367 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 33
Study 18294367 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise programme
Number of subjects: 33
Study 15860436 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of vitamins E and C, beta-carotene, and reduced total, polyunsaturated, and saturated fat intake
Number of subjects: 202
Study 15860436 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E intake
Number of subjects: 202
Study 15860436 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) and polyunsaturated fatty acid (PUFA) intake
Number of subjects: 202
Study 15860436 — intervention group
Group type: EXPERIMENTAL
Intervention: Arachidonic acid intake
Number of subjects: 202
Study 12639206 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydroepiandrosterone (50 mg/d)
Number of subjects: 280
Study 12639206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 11095459 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy (fenfluramine, 60 mg/day) coupled with an energy-restricted diet (−2930 kJ/day)
Number of subjects: 42
Study 11095459 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss protocol (fenfluramine + diet)
Number of subjects: 42
Study 11095459 — intervention group
Group type: COMPARATOR
Intervention: High-insulin individuals
Number of subjects: 42
Study 8842601 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (touchscreen computer-assisted assessment, goal setting, problem-solving counseling)
Number of subjects: 206
Study 8842601 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 206
Study 8842601 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 206
Study 1502965 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge maps
Number of subjects: 111
Study 1502965 — intervention group
Group type: EXPERIMENTAL
Intervention: Scripted cooperation
Number of subjects: 111
Study 1502965 — intervention group
Group type: COMPARATOR
Intervention: Text format
Number of subjects: 111
Study 1502965 — intervention group
Group type: COMPARATOR
Intervention: Individual processing
Number of subjects: 111
Study 6331149 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber supplemented breakfast (F)
Number of subjects: 6
Study 6331149 — intervention group
Group type: COMPARATOR
Intervention: Conventional breakfast (C)
Number of subjects: 6
Study 6331149 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber supplemented lunch (F)
Number of subjects: 6
Study 6331149 — intervention group
Group type: COMPARATOR
Intervention: Conventional lunch (C)
Number of subjects: 6
Study 30994773 — intervention group
Group type: EXPERIMENTAL
Intervention: GLUMA Universal-self-etch
Number of subjects: 20
Study 30994773 — intervention group
Group type: EXPERIMENTAL
Intervention: GLUMA Universal-selective etching
Number of subjects: 20
Study 30994773 — intervention group
Group type: EXPERIMENTAL
Intervention: GLUMA Universal-etch-and-rinse
Number of subjects: 20
Study 30994773 — intervention group
Group type: EXPERIMENTAL
Intervention: All-Bond Universal-self-etch
Number of subjects: 20
Study 30994773 — intervention group
Group type: EXPERIMENTAL
Intervention: All-Bond Universal-selective etching
Number of subjects: 20
Study 30994773 — intervention group
Group type: EXPERIMENTAL
Intervention: All-Bond Universal-etch-and-rinse
Number of subjects: 20
Study 30994773 — intervention group
Group type: COMPARATOR
Intervention: Single Bond2-etch-and-rinse (Control)
Number of subjects: 20
Study 30994773 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 20
Study 29490294 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (60-120 mg/day, intravenously) for 1 week
Number of subjects: 26
Study 29490294 — intervention group
Group type: COMPARATOR
Intervention: Control group (no furosemide or other diuretics)
Number of subjects: 26
Study 27957487 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mA A-tDCS for 15 minutes
Number of subjects: 10
Study 27957487 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study 25268730 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola rosea (364 mg daily for 42 days)
Number of subjects: 48
Study 25268730 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical capsule daily for 42 days)
Number of subjects: 48
Study 22977989 — intervention group
Group type: EXPERIMENTAL
Intervention: Wipe product
Number of subjects: 0
Study 22977989 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray product
Number of subjects: 0
Study 21077563 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliable automation
Number of subjects: 12
Study 21077563 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreliable automation (miss)
Number of subjects: 12
Study 21077563 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreliable automation (false alarm)
Number of subjects: 12
Study 21077563 — intervention group
Group type: COMPARATOR
Intervention: Manual performance
Number of subjects: 12
Study 18689370 — intervention group
Group type: EXPERIMENTAL
Intervention: Bread fortified with 138 µg folic acid and 9.6 µg vitamin B-12 daily
Number of subjects: 142
Study 18689370 — intervention group
Group type: COMPARATOR
Intervention: Unfortified bread
Number of subjects: 142
Study 16199244 — intervention group
Group type: EXPERIMENTAL
Intervention: Muraglitazar 2.5 mg
Number of subjects: 340
Study 16199244 — intervention group
Group type: EXPERIMENTAL
Intervention: Muraglitazar 5 mg
Number of subjects: 340
Study 16199244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 16199244 — intervention group
Group type: EXPERIMENTAL
Intervention: Muraglitazar 5 mg (open-label cohort)
Number of subjects: 340
Study 12553178 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported pesticide exposure among farmworkers
Number of subjects: 571
Study 12553178 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective practices to keep pesticide residues out of the home
Number of subjects: 571
Study 12553178 — intervention group
Group type: EXPERIMENTAL
Intervention: Pesticide levels in urine and dust samples
Number of subjects: 571
Study 10586004 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa vaccine
Number of subjects: 510
Study 10586004 — intervention group
Group type: COMPARATOR
Intervention: Td vaccine with pa vaccine
Number of subjects: 510
Study 10586004 — intervention group
Group type: COMPARATOR
Intervention: dTpa or Td
Number of subjects: 510
Study 10586004 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa and pa vaccines
Number of subjects: 510
Study 8915665 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral micronized progesterone (300 mg/day, at bedtime)
Number of subjects: 299
Study 8915665 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal micronized progesterone (300 mg/day)
Number of subjects: 299
Study 8915665 — intervention group
Group type: COMPARATOR
Intervention: Control group (18 apparently healthy females, no interventions)
Number of subjects: 299
Study 1888621 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac gel (1 g diclofenac/100 g, 80 mg three times daily)
Number of subjects: 10
Study 1888621 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 10
Study 1888621 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac gel
Number of subjects: 10
Study 1888621 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac gel and Placebo gel
Number of subjects: 10
Study 3936085 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg dextroamphetamine sulfate
Number of subjects: 22
Study 3936085 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 22
Study 30328781 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil applied on the face
Number of subjects: 42
Study 30328781 — intervention group
Group type: COMPARATOR
Intervention: Sunflower seed oil applied on the foot
Number of subjects: 42
Study 30328781 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil applied on the foot
Number of subjects: 42
Study 30328781 — intervention group
Group type: COMPARATOR
Intervention: Sunflower seed oil applied on the face
Number of subjects: 42
Study 28599060 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 0
Study 28599060 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 400 mg once daily for 5 days
Number of subjects: 0
Study 28599060 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of sacubitril/valsartan and sildenafil
Number of subjects: 0
Study 26975739 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 225
Study 26975739 — intervention group
Group type: COMPARATOR
Intervention: Axillary dissection (ALND)
Number of subjects: 225
Study 26975739 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Survival (OS)
Number of subjects: 225
Study 26975739 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-Free Survival (EFS)
Number of subjects: 225
Study 24845606 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballroom dancing program (3 sessions of 50 minutes each week for 12 weeks)
Number of subjects: 59
Study 24845606 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 59
Study 22676908 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery for hematoma evacuation and the best medical treatment
Number of subjects: 100
Study 22676908 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (the best medical treatment)
Number of subjects: 100
Study 20810517 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arms
Number of subjects: 32
Study 20810517 — intervention group
Group type: COMPARATOR
Intervention: Placebo groups
Number of subjects: 32
Study 20810517 — intervention group
Group type: EXPERIMENTAL
Intervention: Year of publication
Number of subjects: 32
Study 23035962 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help cognitive behavioral intervention (CBT-I) with six booklets and telephone helpline
Number of subjects: 193
Study 23035962 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help cognitive behavioral intervention (CBT-I)
Number of subjects: 193
Study 23035962 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 193
Study 15830639 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP and 14% doxycycline gel (DOX)
Number of subjects: 110
Study 15830639 — intervention group
Group type: COMPARATOR
Intervention: SRP with subgingival placebo gel (VEH)
Number of subjects: 110
Study 15830639 — intervention group
Group type: COMPARATOR
Intervention: scaling and root planing (SRP) alone
Number of subjects: 110
Study 11852170 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated Influenza Vaccine
Number of subjects: 2032
Study 11852170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2032
Study 9614526 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual field assessment with Goldmann perimetry
Number of subjects: 35
Study 9614526 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual field assessment with Humphrey perimetry
Number of subjects: 35
Study 9614526 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall visual status improvement
Number of subjects: 35
Study 9614526 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual function assessment regime
Number of subjects: 35
Study 8078164 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid test (30-minute enzyme immunoassay test and tissue culture)
Number of subjects: 1526
Study 8078164 — intervention group
Group type: COMPARATOR
Intervention: Cell culture (routine screening clinic)
Number of subjects: 1526
Study 2910293 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar injections (5 mL)
Number of subjects: 79
Study 2910293 — intervention group
Group type: COMPARATOR
Intervention: Periocular injections (5 mL)
Number of subjects: 79
Study 2910293 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 79
Study 5324105 — intervention group
Group type: EXPERIMENTAL
Intervention: dexamethasone-21-phosphate
Number of subjects: 200
Study 5324105 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 200
Study 28873284 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PRP injection
Number of subjects: 50
Study 28873284 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline)
Number of subjects: 50
Study 28749177 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure treatment target of 120 mmHg
Number of subjects: 9361
Study 28749177 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure treatment target of 120 mmHg in the lowest tertile of baseline systolic blood pressure
Number of subjects: 9361
Study 28749177 — intervention group
Group type: COMPARATOR
Intervention: Systolic blood pressure treatment target of 140 mmHg
Number of subjects: 9361
Study 25074436 — intervention group
Group type: EXPERIMENTAL
Intervention: S100A12
Number of subjects: 200
Study 25074436 — intervention group
Group type: EXPERIMENTAL
Intervention: sRAGE
Number of subjects: 200
Study 25074436 — intervention group
Group type: EXPERIMENTAL
Intervention: S100A12/sRAGE ratio
Number of subjects: 200
Study 23829576 — intervention group
Group type: EXPERIMENTAL
Intervention: Football group (FG)
Number of subjects: 20
Study 23829576 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 21435016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cresco components loaded 10 days post-implant placement
Number of subjects: 36
Study 21435016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cresco components loaded 6-8 weeks post-implant placement
Number of subjects: 36
Study 21435016 — intervention group
Group type: COMPARATOR
Intervention: Conventional components loaded 6-8 weeks post-implant placement
Number of subjects: 36
Study 18226677 — intervention group
Group type: EXPERIMENTAL
Intervention: Carraguard gel
Number of subjects: 152
Study 16458540 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-Hz magnetic field exposure for 5 consecutive nights
Number of subjects: 0
Study 16458540 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 0
Study 12730861 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL#3 (1 packet containing 900 billion bacteria/day)
Number of subjects: 40
Study 12730861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12730861 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL#3
Number of subjects: 40
Study 10919344 — intervention group
Group type: EXPERIMENTAL
Intervention: Flucozole (200 mg)
Number of subjects: 12
Study 10919344 — intervention group
Group type: COMPARATOR
Intervention: Diflucan (200 mg)
Number of subjects: 12
Study 8977634 — intervention group
Group type: EXPERIMENTAL
Intervention: DC pulsed with PSM-P2 (group 5)
Number of subjects: 0
Study 8977634 — intervention group
Group type: EXPERIMENTAL
Intervention: DC pulsed with PSM-P1 (group 4)
Number of subjects: 0
Study 8977634 — intervention group
Group type: COMPARATOR
Intervention: Peptides alone (PSM-P1 or PSM-P2; groups 1 and 2)
Number of subjects: 0
Study 8977634 — intervention group
Group type: COMPARATOR
Intervention: Autologous DC (group 3)
Number of subjects: 0
Study 8977634 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 0
Study 3880556 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (10-15 mg daily)
Number of subjects: 488
Study 3880556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 488
Study 31804571 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography (performed a median of 16 days following peritoneal dialysis initiation)
Number of subjects: 99
Study 28495124 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual demonstration of themselves as a lifelong smoker and non‐smoker
Number of subjects: 98
Study 28495124 — intervention group
Group type: COMPARATOR
Intervention: Standard smoking cessation counselling sessions
Number of subjects: 98
Study 26951242 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Intervention Group (IIG)
Number of subjects: 27
Study 26951242 — intervention group
Group type: COMPARATOR
Intervention: Minimal Intervention Group (MIG)
Number of subjects: 27
Study 24394343 — intervention group
Group type: EXPERIMENTAL
Intervention: TRPV1 antagonist AZD1386
Number of subjects: 0
Study 23095629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological postconditioning with sevoflurane
Number of subjects: 115
Study 23095629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent clamping
Number of subjects: 115
Study 23095629 — intervention group
Group type: COMPARATOR
Intervention: Control group (continuous inflow occlusion)
Number of subjects: 115
Study 20881647 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzastaurin 500 mg orally daily (after a loading dose) plus pemetrexed 500 mg/m², carboplatin AUC 6, and bevacizumab 15 mg/kg intravenously every 21 days for four cycles.
Number of subjects: 40
Study 20881647 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus pemetrexed 500 mg/m², carboplatin AUC 6, and bevacizumab 15 mg/kg intravenously every 21 days for four cycles.
Number of subjects: 40
Study 18590751 — intervention group
Group type: EXPERIMENTAL
Intervention: Washing mouth with water
Number of subjects: 15
Study 18590751 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing to increase saliva volume
Number of subjects: 15
Study 18590751 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary proteins
Number of subjects: 15
Study 18590751 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mucosal wetness
Number of subjects: 15
Study 15804153 — intervention group
Group type: EXPERIMENTAL
Intervention: PMEA (X-coating)
Number of subjects: 60
Study 15804153 — intervention group
Group type: COMPARATOR
Intervention: CTR (control)
Number of subjects: 60
Study 12126042 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis patients (n=50)
Number of subjects: 93
Study 12126042 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhosis patients (n=25)
Number of subjects: 93
Study 12126042 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (n=18)
Number of subjects: 93
Study 7782179 — intervention group
Group type: EXPERIMENTAL
Intervention: non‐restricted diet of foods preselected and usually eaten by the child
Number of subjects: 100
Study 7782179 — intervention group
Group type: COMPARATOR
Intervention: restricted diet of only soft foods and liquids
Number of subjects: 100
Study 2169078 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Fragmin) at a dose of 75 U/kg/day for 5 days (I group, n = 27)
Number of subjects: 56
Study 2169078 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Fragmin) at a dose of 150 U/kg/day for 5 days (II group, n = 29)
Number of subjects: 56
Study 2169078 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified, but includes cases that died of underlying diseases or complications)
Number of subjects: 56
Study 2169078 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified, but includes cases with hemorrhagic side effects)
Number of subjects: 56
Study 75391 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 30
Study 75391 — intervention group
Group type: EXPERIMENTAL
Intervention: Flufenamic acid
Number of subjects: 30
Study 75391 — intervention group
Group type: COMPARATOR
Intervention: Dextropropoxyphene/paracetamol
Number of subjects: 30
Study 31885120 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skills training (CST) + standard care (SC)
Number of subjects: 100
Study 31885120 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 100
Study 30860393 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous neuromodulation (PNM)
Number of subjects: 45
Study 30860393 — intervention group
Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 45
Study 30860393 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise
Number of subjects: 45
Study 28017166 — intervention group
Group type: EXPERIMENTAL
Intervention: Interlaminar epidural steroid injections
Number of subjects: 299
Study 28017166 — intervention group
Group type: COMPARATOR
Intervention: Transforaminal epidural steroid injections
Number of subjects: 299
Study 25942474 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 mmol NO3(‐) supplementation
Number of subjects: 10
Study 25942474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 24495046 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) for 5 days and rectal enema
Number of subjects: 50
Study 24495046 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 50
Study 24495046 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS)
Number of subjects: 50
Study 22784287 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydroxyethyl starch (HES)
Number of subjects: 30
Study 22784287 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% human albumin (HA)
Number of subjects: 30
Study 22784287 — intervention group
Group type: COMPARATOR
Intervention: Ringer's solution (RS)
Number of subjects: 30
Study 19960971 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangyin Jiedu Huoxue Recipe (YJHR) plus conventional Western medical treatment
Number of subjects: 78
Study 19960971 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medical treatment only (Control)
Number of subjects: 78
Study 17613964 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg per day
Number of subjects: 76